Estimation of cost-based prices for injectable medicines in the WHO Essential Medicines List
Objectives Challenges remain in ensuring universal access to affordable essential medicines. We previously estimated the expected generic prices based on cost of production for medicines in solid oral formulations (ie, capsules or tablets) on the WHO Model List of Essential Medicines (EML). The obje...
Saved in:
| Main Authors: | Dzintars Gotham, Melissa Joy Barber, Andrew M Hill |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2019-09-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/9/9/e027780.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison Between Latest National Essential Medicine List and Latest WHO Essential Medicine List
by: Pradeep ., et al.
Published: (2025-01-01) -
Trends in cost and consumption of essential medicines for non-communicable diseases in Azerbaijan, Georgia, and Uzbekistan, from 2019 to 2021.
by: Ninell Kadyrova, et al.
Published: (2023-01-01) -
Time to inclusion of selected medicines for priority diseases in National Essential Medicines Lists compared with the WHO Model List
by: Fatima Suleman, et al.
Published: (2025-06-01) -
Essentials of Medicines and Health Supplies List for Uganda /
Published: (2016) -
WHO essential medicines for reproductive health
by: Fernando Althabe, et al.
Published: (2019-12-01)